Center-Authored Papers

Filters: Author is Massard, Christophe  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Thiazoles
Pyrimidines
Public Health Sciences Division
Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C et al..  2014.  Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(1):246-52. Abstract
Protein Kinase Inhibitors
Prostatic Neoplasms
Neoplasm Metastasis
Middle Aged
Male
Humans
Gonadotropin-Releasing Hormone
February 2014
Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C et al..  2014.  Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(1):246-52. Abstract
Drug Resistance, Neoplasm
Drug Administration Schedule
Consortium Authored Paper
Aged, 80 and over
Aged
2014
Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C et al..  2014.  Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(1):246-52. Abstract